Comparative Analysis of the Stability and Performance of Double-, Triple-, and Quadruple-Cation Perovskite Solar Cells for Rooftop and Indoor Applications.
Shahriyar Safat DiptaAshraful Hossain HowladerWalia Binte TariqueAshraf UddinPublished in: Molecules (Basel, Switzerland) (2024)
The solar energy market is predicted to be shared between Si solar cells and third-generation photovoltaics in the future. Perovskite solar cells (PSCs) show the greatest potential to capture a share there as a single junction or in tandem with silicon. Researchers worldwide are looking to optimize the composition of the perovskite film to achieve an optimal bandgap, performance, and stability. Traditional perovskites have a mixture of formamidinium and methyl ammonium as the A-site cation in their ABX 3 structure. However, in recent times, the use of cesium and rubidium has become popular for making highly efficient PSCs. A thorough analysis of the performance and stability of double-, triple-, and quadruple-cation PSCs under different environmental conditions was performed in this study. The performance of the device and the films was analyzed by electrical measurements (J-V, dark J-V, EQE), scanning electron microscopy, atomic force microscopy, photoluminescence, and X-ray diffraction. The quadruple-cation device with the formula Cs 0.07 Rb 0.03 FA 0.77 MA 0.13 PbI 2.8 Br 0.2 showed the highest power conversion efficiency (PCE) of 21.7%. However, this device had the least stability under all conditions. The triple-cation device with the formula Cs 0.1 FA 0.6 MA 0.3 PbI 2.8 Br 0.2 , with a slightly lower PCE (21.2%), was considerably more stable, resulting in about 30% more energy harvested than that using the other two devices during their life cycle.
Keyphrases
- perovskite solar cells
- electron microscopy
- ionic liquid
- room temperature
- solar cells
- helicobacter pylori
- highly efficient
- life cycle
- atomic force microscopy
- helicobacter pylori infection
- high resolution
- high speed
- air pollution
- human health
- preterm infants
- risk assessment
- single molecule
- health insurance
- magnetic resonance